Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.71B |
| 2 |
Eli Lilly
LLY
|
$1.55B |
| 3 |
Tesla
TSLA
|
$1.14B |
| 4 |
Tractor Supply
TSCO
|
$1.01B |
| 5 |
Boeing
BA
|
$935M |
Top Sells
| 1 |
Apple
AAPL
|
$1.79B |
| 2 |
Visa
V
|
$1.57B |
| 3 |
General Dynamics
GD
|
$1.55B |
| 4 |
Morgan Stanley
MS
|
$1.29B |
| 5 |
Exelon
EXC
|
$1.15B |
Sector Composition
| 1 | Technology | 24.19% |
| 2 | Healthcare | 17.87% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
UBS Group
UBS
$126B
| $395M | 0.07% |
12,921,485
-787,138
| -6% | -$24.1M |
|
227
CyberArk
CYBR
$22.8B
| $383M | 0.07% |
1,150,278
-238,567
| -17% | -$79.5M |
|
228
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.45B
| $380M | 0.07% |
14,155,411
+949,253
| +7% | +$25.5M |
|
229
Roper Technologies
ROP
$55.9B
| $379M | 0.07% |
728,742
-9,840
| -1% | -$5.12M |
|
230
Apellis Pharmaceuticals
APLS
$3.56B
| $377M | 0.07% |
11,800,849
-3,766,120
| -24% | -$120M |
|
231
EOG Resources
EOG
$68.8B
| $375M | 0.07% |
3,058,263
-1,469,904
| -32% | -$180M |
|
232
Idacorp
IDA
$6.73B
| $374M | 0.07% |
3,424,956
+1,035,133
| +43% | +$113M |
|
|
BPMC
233
DELISTED
Blueprint Medicines
BPMC
| $373M | 0.07% |
4,281,364
+316,754
| +8% | +$27.6M |
|
234
Veeva Systems
VEEV
$44.1B
| $373M | 0.07% |
1,775,963
-4,352
| -0.2% | -$915K |
|
235
Encompass Health
EHC
$12.5B
| $372M | 0.07% |
4,030,442
-1,189,732
| -23% | -$110M |
|
236
Dayforce
DAY
$11B
| $371M | 0.07% |
5,112,210
-1,283,003
| -20% | -$93.2M |
|
237
Cytokinetics
CYTK
$5.94B
| $371M | 0.07% |
7,888,697
+113,727
| +1% | +$5.35M |
|
238
NVR
NVR
$22.6B
| $365M | 0.07% |
44,632
-6,701
| -13% | -$54.8M |
|
239
MongoDB
MDB
$26B
| $364M | 0.07% |
1,563,699
-1,595,726
| -51% | -$372M |
|
240
Morningstar
MORN
$10.8B
| $364M | 0.07% |
1,080,599
+130,087
| +14% | +$43.8M |
|
241
Vaxcyte
PCVX
$4.1B
| $364M | 0.07% |
4,444,012
-69,744
| -2% | -$5.71M |
|
242
Voya Financial
VOYA
$7.18B
| $360M | 0.07% |
5,231,860
-1,359,433
| -21% | -$93.6M |
|
243
Freshpet
FRPT
$2.67B
| $358M | 0.07% |
2,419,323
-108,163
| -4% | -$16M |
|
244
Ingersoll Rand
IR
$31B
| $358M | 0.07% |
3,953,566
-157,747
| -4% | -$14.3M |
|
245
Pool Corp
POOL
$11.4B
| $355M | 0.07% |
1,042,514
+224,674
| +27% | +$76.6M |
|
246
Crinetics Pharmaceuticals
CRNX
$3.14B
| $355M | 0.07% |
6,950,567
+2,490,876
| +56% | +$127M |
|
247
Novartis
NVS
$245B
| $355M | 0.07% |
3,647,861
-351,314
| -9% | -$34.2M |
|
248
Palantir
PLTR
$373B
| $354M | 0.06% |
4,682,230
+3,907,022
| +504% | +$295M |
|
249
Dover
DOV
$24.1B
| $352M | 0.06% |
1,877,371
-53,164
| -3% | -$9.97M |
|
250
Hilton Worldwide
HLT
$64.9B
| $352M | 0.06% |
1,422,982
-51,992
| -4% | -$12.9M |
|